Cargando…

Influenza virus polymerase inhibitors in clinical development

PURPOSE OF REVIEW: We review antivirals inhibiting subunits of the influenza polymerase complex that are advancing in clinical development. RECENT FINDINGS: Favipiravir, pimodivir, and baloxavir are inhibitory in preclinical models for influenza A viruses, including pandemic threat viruses and those...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayden, Frederick G., Shindo, Nahoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Special Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416007/ https://www.ncbi.nlm.nih.gov/pubmed/30724789 http://dx.doi.org/10.1097/QCO.0000000000000532

Ejemplares similares

Editorial Commentary: Host and Viral Factors in Emergent Influenza Virus Infections
por: Hui, David S., et al.
Publicado: (2014)

mSphere of Influence: Resolution of the Structure of an Influenza Virus Polymerase Is a Game Changer
por: Richard, Mathilde
Publicado: (2019)

Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects
por: Hayden, Frederick G.
Publicado: (2009)

The hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infection
por: Sellers, Subhashini A., et al.
Publicado: (2017)

Bacterial and viral infections associated with influenza
por: Joseph, Carol, et al.
Publicado: (2013)

Baloxavir Marboxil in Japanese Pediatric Patients With Influenza: Safety and Clinical and Virologic Outcomes
por: Hirotsu, Nobuo, et al.
Publicado: (2020)

Drug Repurposing for Influenza Virus Polymerase Acidic (PA) Endonuclease Inhibitor
por: Meng, Xin, et al.
Publicado: (2021)

mSphere of Influence: Redefining an Influenza Virus—How Different Are Influenza Viruses and Extracellular Vesicles?
por: Lakdawala, Seema S.
Publicado: (2019)

Advances in antivirals for non‐influenza respiratory virus infections
por: Hayden, Frederick G.
Publicado: (2013)

Factors Underlying Ebola Virus Infection Among Health Workers, Kenema, Sierra Leone, 2014–2015
por: Senga, Mikiko, et al.
Publicado: (2016)

Unusual Influenza A Viruses in Bats
por: Mehle, Andrew
Publicado: (2014)

Seasonality of influenza and other respiratory viruses
por: Neumann, Gabriele, et al.
Publicado: (2022)

New vaccines against influenza virus
por: Lee, Young-Tae, et al.
Publicado: (2014)

Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention
por: Hayden, Frederick G.
Publicado: (2000)

Influenza Virus Resistance to Human Neutralizing Antibodies
por: Crowe, James E.
Publicado: (2012)

Nucleoproteins of Negative Strand RNA Viruses; RNA Binding, Oligomerisation and Binding to Polymerase Co-Factor
por: Ruigrok, Rob W.H., et al.
Publicado: (2010)

Susceptibility of widely diverse influenza a viruses to PB2 polymerase inhibitor pimodivir
por: Patel, Mira C., et al.
Publicado: (2021)

A Host of Factors Regulating Influenza Virus Replication
por: Mehle, Andrew, et al.
Publicado: (2010)

Staphylococcus aureus and Influenza A Virus: Partners in Coinfection
por: Mulcahy, Michelle E., et al.
Publicado: (2016)

Female Antibodies Go the Distance against Influenza Viruses
por: Good, Marina R., et al.
Publicado: (2022)

The ubiquitination landscape of the influenza A virus polymerase
por: Günl, Franziska, et al.
Publicado: (2023)

Virus-like particle (VLP)-based vaccines for pandemic influenza: Performance of a VLP vaccine during the 2009 influenza pandemic
por: López-Macías, Constantino
Publicado: (2012)

The Effect of Influenza Virus on the Human Oropharyngeal Microbiome
por: Ramos-Sevillano, Elisa, et al.
Publicado: (2019)

The role of respiratory epithelium in host defence against influenza virus infection()
por: Denney, Laura, et al.
Publicado: (2018)

Inflammasomes in antiviral immunity: clues for influenza vaccine development
por: Yamazaki, Tatsuya, et al.
Publicado: (2014)

The prevalence and implications of single nucleotide polymorphisms in genes encoding the RNA polymerase of clinical isolates of Staphylococcus aureus
por: Krishna, Aishwarya, et al.
Publicado: (2020)

Viral Kinetics and Resistance Development in Children Treated with Neuraminidase Inhibitors: The Influenza Resistance Information Study (IRIS)
por: Roosenhoff, Rueshandra, et al.
Publicado: (2020)

Polymerase chain reaction–based detection of rhinovirus, respiratory syncytial virus, and coronavirus in otitis media with effusion()()()()
por: Pitkäranta, Anne, et al.
Publicado: (1998)

Semisynthetic Cardenolides Acting as Antiviral Inhibitors of Influenza A Virus Replication by Preventing Polymerase Complex Formation
por: Boff, Laurita, et al.
Publicado: (2020)

Active RNA polymerase II curbs chromatin movement
por: Hochberg-Laufer, Hodaya, et al.
Publicado: (2019)

The bridge helix coordinates movements of modules in RNA polymerase
por: Hein, Pyae P, et al.
Publicado: (2010)

Polymerase θ inhibition steps on the cGAS pedal
por: Smith, Chelsea M., et al.
Publicado: (2023)

An attempt to establish real-world databases of poly(ADP-ribose) polymerase inhibitors for advanced or recurrent epithelial ovarian cancer: the Japanese Gynecologic Oncology Group
por: Shimada, Muneaki, et al.
Publicado: (2023)

Investigating Influenza Virus Polymerase Activity in Feline Cells Based on the Influenza Virus Minigenome Replication System Driven by the Feline RNA Polymerase I Promoter
por: Lu, Gang, et al.
Publicado: (2022)

Research on Highly Pathogenic H5N1 Influenza Virus: The Way Forward
por: Fauci, Anthony S.
Publicado: (2012)

IFN-λ: A new spotlight in innate immunity against influenza virus infection
por: Sun, Yeping, et al.
Publicado: (2018)

Human infection with Avian influenza A virus in Nepal: requisite for timely management and preparedness
por: Acharya, Krishna Prasad, et al.
Publicado: (2020)

Poly-ADP Ribosyl Polymerase 1 (PARP1) Regulates Influenza A Virus Polymerase
por: Westera, Liset, et al.
Publicado: (2019)

Trends in clinical development of pediatric cancer for PD-1 and PD-L1 inhibitors: an analysis of ClinicalTrials.gov
por: Que, Yi, et al.
Publicado: (2021)

Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic
por: Wiemken, Timothy L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1bujc9bgck2vfs8j7dfiuq4r8j